Title : Blood pressure response, but not adverse event incidence, correlates with dose of angiotensin II antagonist.

Pub. Date : 2001 Jun

PMID : 11451214






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To assess the efficacy and safety of the novel angiotensin II antagonist olmesartan medoxomil in patients with mild to moderate essential hypertension, using a meta-analysis of the combined database from seven US and European clinical trials. olmesartan angiotensinogen Homo sapiens